Login
| TI Ref No : | 530059743 |
|---|---|
| Description : | Contract Awarded For Conclusion Of A Non-exclusive Discount Agreement According To § 130a Paragraph 8 Sgb V For The Active Ingredient Tildrakizumab, Atc L04ac17 For The Period 01.01.2024 - 31.12.2025 § 130a Paragraph 8 Sgb V Allows Health Insurance Compan |
| Date : | 2026-03-08 |
| Deadline : | 2026-04-13 |
| Document Type : | Contracts |
